Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentric, Single Arm, Phase II Trial Assessing the Efficacy of Niraparib as First Line Therapy for Patients With Metastatic Homologous Repair-deficient Pancreatic Cancer

NCT05442749 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT05442749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentric, Single Arm, Phase II Trial Assessing the Efficacy of Niraparib as First Line Therapy for Patients With Metastatic Homologous Repair-deficient Pancreatic Cancer
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Terminated
Start date
October 28, 2022
Completion date
August 30, 2024
Enrollment
2 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic cancer